Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
402 INR | +3.80% | +11.79% | -11.11% |
05-10 | Sharda Cropchem Limited Proposes Dividend for Financial Year 2023-2024 | CI |
01-25 | Transcript : Sharda Cropchem Limited, Q3 2024 Earnings Call, Jan 25, 2024 |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
- According to Refinitiv, the company's ESG score for its industry is poor.
Strengths
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 180.14 times its estimated earnings per share for the ongoing year.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-11.11% | 418M | D+ | ||
+19.57% | 39.94B | C | ||
-.--% | 11.21B | - | B+ | |
+5.80% | 8.33B | A | ||
+3.50% | 6.65B | B- | ||
-3.19% | 6.09B | B+ | ||
-6.17% | 5.6B | B | ||
+39.42% | 5.52B | B- | ||
-18.29% | 4.99B | - | C- | |
-14.09% | 4.8B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SHARDACROP Stock
- Ratings Sharda Cropchem Limited